CAS Number571170-77-9
SynonymsLaropiprant; Laropiprant (INN/USAN); cc-711; MFCD11042421; MK 0524; UNII-G7N11T8O78; MK-0524
Molecular FormulaC21H19ClFNO4S
Molecular Weight435.90
Purity≥98 (HPLC)%
Density1.5±0.1 g/cm3
Boiling Point710.0±60.0 °C at 760 mmHg
Melting Point175∶ºC
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 571170-77-9 |
| Catalog No. | 2A-1175015 |
| Chinese Name | 拉罗皮兰 |
| Synonyms | Laropiprant; Laropiprant (INN/USAN); cc-711; MFCD11042421; MK 0524; UNII-G7N11T8O78; MK-0524 |
| Molecular Formula | C21H19ClFNO4S |
| Molecular Weight | 435.90 |
| Purity | ≥98 (HPLC) |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 710.0±60.0 °C at 760 mmHg |
| Melting Point | 175∶ºC |
| Appearance | powder |
| Storage Condition | -20°C |
| Application | Laropiprant is a potent, selective DP receptor antagonist with a Ki of 0.57 nM and a Ki of 2.95 nM for the TP receptor. |
| PubChem ID | 14832522 |
| MDL Number | MFCD11042421 |
| SMILES | OC(C[C@@H](CC1)C2=C1C3=CC(F)=CC(S(C)(=O)=O)=C3N2CC4=CC=C(C=C4)Cl)=O |
| InChI | 1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1 |
| InChI Key | NXFFJDQHYLNEJK-CYBMUJFWSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/175416_1_571170_77_9.pdf |
| Transport Info | Product Name: Laropiprant |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| WP1130 | 856243-80-6 | 2A-1175007 |
| PH 797804 | 586379-66-0 | 2A-1175008 |
| ICG-001 | 847591-62-2 | 2A-1175010 |
| TAK-700 | 426219-18-3 | 2A-1175012 |
| TAK-700 | 426219-53-6 | 2A-1175013 |
| ARRY-334543 | 845272-21-1 | 2A-1175016 |
| MRS 2578 | 711019-86-2 | 2A-1175017 |
| GSK series | 1093818-24-6 | 2A-1175018 |
| PF03716556 | 928774-43-0 | 2A-1175022 |
| ly2603618 IC-83 | 911222-45-2 | 2A-1175023 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS